GLP-1 analogs, such as exenatide and liraglutide, have neuroprotective effects in animal models of Alzheimer's disease (AD) (Athauda and Foltynie [44]). The gene discussed is GCG; the disease is early-onset autosomal dominant Alzheimer disease.